{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-030125","form_type":"8-K","ticker":"GOVX","cik":"0000832489","company_name":"GeoVax Labs, Inc.","filed_at":"2025-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.470896+00:00","generated_at":"2026-05-17T05:20:43.480514+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"GeoVax raises ~$2.5M in registered direct offering; issues shares and warrants at $0.63","bullets":["3,968,256 shares sold at $0.63 each with warrants to buy 11,904,768 shares at $0.63.","Gross proceeds ~$2.5M, net ~$2.325M after 7% placement agent fees.","Warrants exercisable only upon shareholder approval; expire 5 years from approval.","Roth Capital Partners acted as sole placement agent for the offering.","Proceeds to advance immunotherapies and vaccines pipeline including R&D and clinical studies."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-030125","json":"https://secwatch.observer/filing/0001437749-25-030125.json","markdown":"https://secwatch.observer/filing/0001437749-25-030125.md","text":"https://secwatch.observer/filing/0001437749-25-030125.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774925030125/0001437749-25-030125-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774925030125/govx20250930_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:20:43.480514+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"35043b34dd23b6f055273d6007213d3246048879","claim":"GeoVax Labs, Inc. issued 11,904,768 shares of Common Stock of warrant.","evidence_excerpt":"In a concurrent private placement, the Company offered common warrants to the purchasers, with each warrant exercisable to purchase one share of Common Stock (the “Common Warrants”), with three Common Warrant to accompany each share of Common Stock sold in the Offering, and to purchase in the aggregate of 11,904,768 shares of Common Stock (the “Common Warrant Shares”).","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925030125/0001437749-25-030125-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"11,904,768 shares of Common Stock"}],"fact_type":"equity_issuance"},{"claim_id":"f99a33720c7041831a421882f8cbeedeb07ecca6","claim":"GeoVax Labs, Inc. issued 3,968,256 shares of common stock for $0.63 per Share.","evidence_excerpt":"share of Common Stock sold in the Offering, and to purchase in the aggregate of 11,904,768 shares of Common Stock (the “Common Warrant Shares”). The public offering price was $0.63 for each Share coupled with the Common Warrants. The Common Warrants have an exercise price of $0.63 per share. Under the terms of the Purchase Agreement and to comply with Nasdaq","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774925030125/0001437749-25-030125-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"3,968,256 shares"},{"label":"Consideration","value":"$0.63 per Share"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}